
CAS 2237268-08-3
:Formula:C19H22N4O4S
InChI:InChI=1S/C19H22N4O4S/c24-19(21-11-14-7-9-20-10-8-14)22-15-1-5-18(6-2-15)28(25,26)23-12-16-3-4-17(13-23)27-16/h1-2,5-10,16-17H,3-4,11-13H2,(H2,21,22,24)
InChI key:KTSOHNHLOLGQCY-UHFFFAOYSA-N
SMILES:C1CC2CN(CC1O2)S(=O)(=O)C3=CC=C(C=C3)NC(=O)NCC4=CC=NC=C4
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
SBI-797812
CAS:SBI-797812 is structurally similar to active-site directed inhibitor of NAMPT(NAMPT with EC50 of 0.37 μM).Formula:C19H22N4O4SPurity:99.31%Color and Shape:White SolidMolecular weight:402.467SBI-797812
CAS:1-(4-((8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)sulfonyl)phenyl)-3-(pyridin-4-ylmethyl)ureaFormula:C19H22N4O4SPurity:98%Molecular weight:402.47SBI-797812
CAS:SBI-797812 is a small molecule that targets the cellular protein, stabilin-1. It has been shown to suppress the degradation of stabilin-1 and stabilize it in cells from animals and humans. When this drug binds to stabilin-1, it prevents the binding of destabilizing molecules and increases the stability of stabilin-1. This drug also has been shown to boost levels of stabilin-1 in tissues from mice by increasing the biosynthesis of mononucleotides. SBI-797812 has potential as a treatment for diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis.Formula:C19H22N4O4SPurity:Min. 95%Molecular weight:402.47 g/mol




